Code | 8902B | ||||||||||
MA number | 34/0179/16-S | ||||||||||
Product Form: | sol iru 2x5 ml/250 mg (striek.inj.napl.+ihly) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 34 - ANTIHORMONA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | pre-filled syringe | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 12.04.2016 |
Pediatric warnings: | Yes |
SPC: | SPC_Fulvestrant Teva 250 mg_03_2021.pdf |
PIL: | PIL_Fulvestrant Teva 250 mg_03_2021.pdf |
Safety feature | Yes |
Data update: | 19.11.2020 |